SMF
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF (NCT01644110) | University of Ulm | 2013-08-01 |
Track SMF automatically
Every clearance here is in the API, with alerts when new ones post.